Other study drug-related TEAEs, all of which occurred in one patient each, included infusion site pruritus, thirst, and hot flush in patients who received FCM 7.5 mg/kg and upper abdominal pain, gastroduodenitis, hyperthermia, injection site pain, increased alanine aminotransferase levels, headache, pruritus, rash, and hypertension in patients who received FCM 15 mg/kg. This evidence concerns the gene GPT and gastroduodenitis.